A securities class action says Embecta executives told investors the insulin pen franchise was "incredibly resolute" while the numbers underneath were already breaking. On May 5, 2026, the stock collapsed 57.8 percent in a single trading day.
By Mark Tell · Jul 7
Daily at 6AM Eastern
See the pitch they're running today.
Financial crime intelligence. The patterns, the tells, the playbook. Daily at 6AM before anyone asks you for money.
By subscribing you agree to receive the daily MarkTell digest. Free forever. Unsubscribe anytime.
The MarkTell Daily
Tomorrow's pitch, decoded today.
Financial crime intelligence. The patterns, the tells, the playbook. Daily at 6AM before anyone asks you for money.
By subscribing you agree to receive the daily MarkTell digest. Free forever. Unsubscribe anytime.
